v3.19.3
Organization and Summary of Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2019
Accounting Policies [Abstract]  
Schedule of potential common shares of anti-dilutive

For the Nine Months Ended September 30,  2019  2018
Shares Issuable Upon Exercise of Outstanding Warrants - Series RX-2   98,131,600    —   
Shares Issuable Upon Exercise of Outstanding Warrants - Series RX-3   481,212,000    —   
Shares Issuable Upon Conversion of Outstanding Convertible Note Payables   —      298,510,401 
     Total weighted average anti-dilutive potential common shares   579,343,600    298,510,401 

Schedule of dilutive potential common shares

   For the Three Months Ended September 30,  For the Nine Months Ended September 30,
   2019  2018  2019  2018
Weighted-average Common Shares   722,836,769    533,913,355    718,732,314    532,994,267 
Effect of Dilutive Securities:                    
     Weighted-average of Shares Issuable Upon Conversion of Preferred Stock Series RX-1   141,861,500    —      57,160,311    —   
Dilutive Potential Common Shares   864,698,269    533,913,355    775,892,626    532,994,267